Eyedetec Medical (Eyedetec) is developing advanced, proprietary technology treating Dry Eye Disease that impacts 350 million+ adults globally, and the incidence is increasing across all age groups. In many cases, if left untreated, DED leads to serious ocular complications, visual dysfunction, and decreased quality of life. Our new technology will substantially reduce treatment cost, laborious processes and painful impact for the patient.